查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855464

球蟲藥物市場依最終用途、通路、產品類型及劑型分類－2025-2032年全球預測

Anticoccidial Drugs Market by End Use, Distribution Channel, Product Type, Form - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，球蟲藥物市場規模將達到 37.1 億美元，複合年成長率為 9.71%。

關鍵市場統計數據
基準年 2024 17.6億美元
預計年份：2025年 19.3億美元
預測年份 2032 37.1億美元
複合年成長率 (%) 9.71%

簡單介紹球蟲療法在現代動物健康管理中的策略重要性

在集約化畜牧系統中，球蟲藥物對於維持腸道健康和生產效率至關重要。隨著畜牧業生產集約化程度的提高，針對性化學預防和治療性介入的作用日益凸顯，以應對降低生產力、動物福利和飼料轉換率的疾病壓力。在此背景下，對於獸醫團隊、飼料生產商、監管機構和商業性相關人員而言，了解不斷發展的球蟲治療方法至關重要，因為他們需要在療效、安全性和永續性之間尋求平衡。

本報告整合了近期科學進展、監管措施、不斷變化的經銷管道以及終端用戶動態，全面展現了現代球蟲的實踐現狀。報告探討了產品配方選擇、物種特異性飼養方式的轉變以及新出現的抗藥性模式如何影響治療方法的選擇和供應鏈檢驗。透過建立當前實踐和新興壓力的清晰基準，本分析為循證研究投資、市場准入和政策參與提供了支持。

在整個分析過程中，我們將重點放在對決策者的實際影響：配方和交付選擇如何與農場工作流程交織，分銷模式如何影響可及性和管理，監管和貿易發展如何影響採購和生產策略等等。引言部分討論了變革性轉變、關稅影響、細分市場洞察、區域差異、競爭對手行動、可操作的建議、方法論和總體結論，以指南後續章節中的營運和策略應對措施。

畜牧業球蟲藥物研發、使用模式和管理正在發生變革性轉變

近期趨勢將科學、監管和市場因素融合在一起，正在改變球蟲療法的研發、分銷和應用方式。病原體基因組學和體外藥敏試驗的進步提高了我們檢測和監測抗藥性的能力，從而能夠開發更有針對性的產品並制定局部治療策略。同時，動物福利的迫切需求和零售商主導的品質標準正促使生產商重新評估預防方法，轉而採用綜合疾病管理方法，以減少對含藥飼料的使用。

同時，產品格局也在不斷演變。離子載體因其高效性和飼料相容性而備受青睞，而合成化合物在治療抗藥性或在特定生命週期階段需要使用時仍然發揮著重要作用。配方創新，例如改良的預混合料和穩定劑，能夠提高給藥精度，並更輕鬆地整合到飼料和飲水系統中。分銷管道也在改變。直銷關係和專科獸醫診所管道正在加強，而數位平台和線上藥局則擴大了產品的可及性，並改變了消費者的購買行為。

此外，永續性和監管合規性方面的考慮正在推動供應鏈重組。製造商和飼料整合商正在投資上游品管、可追溯性和替代採購，以降低貿易中斷和監管變化的風險。總而言之，這些變化正在重塑整個球蟲生態系統的競爭動態、研究重點和商業實踐，這就要求藥物研發商、委託製造、飼料公司和動物服務供應商制定相應的適應策略。

分析美國2025年宣布的關稅對球蟲供應鏈和採購的累積營運和策略影響

2025年實施的關稅措施對整個球蟲藥物供應鏈、生產投入和分銷環節都產生了連鎖反應。對某些活性藥物成分和飼料中間體徵收的進口關稅增加了依賴海外採購的生產商和飼料廠的到岸成本。為此，採購團隊正在重新評估其供應商組合，優先考慮替代來源，尋找可節省成本的生產窗口，並加強與契約製造的溝通，以減少利潤下滑。

這些由關稅主導的調整也加速了近岸外包的考量與投資。擁有靈活生產佈局的公司正在重新分配生產或增加庫存緩衝，以維持供應的連續性。同時，由於避險能力有限，小型生產者和區域飼料整合商面臨更顯著的成本壓力，促使他們進行整合和建立策略聯盟，以共用規模優勢。關稅帶來的監管合規和海關手續的複雜性增加了行政成本，延長了交貨時間，並影響了訂單排序。

重要的是，分銷管道已適應關稅帶來的成本變化。直銷團隊和專業經銷商加強了與客戶基於價值的對話，強調配方優勢和能夠證明高價合理的管理計劃。線上藥局和數位化採購平台可幫助一些買家從未受影響的地區採購替代配方和學名藥，但品質保證和法規遵循仍然是主要的資訊來源。總體而言，關稅的累積影響迫使企業重組籌資策略並增加對營運韌性的投資，從而影響了整個球蟲價值鏈的商業性定位。

整合最終用途、分銷管道、產品類型和配方選項等關鍵細分洞察，有助於制定有針對性的策略舉措。

市場區隔明確了治療需求與推廣障礙的交會點。根據最終用途，市場細分涵蓋牛、家禽和豬，其中家禽市場也細分為不同的生產系統：肉雞和蛋雞。這些物種和系統層面的差異導致了不同的治療時機、給藥策略以及與飼料管理實踐的整合。飼料添加劑配方和浸沒式治療方案與肉雞的生長週期和蛋雞的飼養管理方式不盡相同，因此需要分別進行產品開發和市場推廣。同一物種內不同治療層級之間的轉換也因生產規模、生物安全通訊協定以及零售商和加工商的具體要求而異。

從分銷管道細分來看，市場研究涵蓋了直銷、線上藥局和專賣店三大通路，每種通路都為終端用戶提供了不同的購買途徑和不同程度的技術支援。直銷通常輔以綜合管理計畫和正式的用藥指導，而線上藥局雖然擴大了購買管道，但需要強大的數位化資訊支援才能確保正確用藥。在獨立獸醫診所和飼料合作社高度集中的地區，專賣店發揮關鍵作用，它們提供的社區諮詢服務能夠影響產品選擇和對推薦通訊協定的遵循。

按產品類型進行細分有助於明確臨床應用和抗藥性管理策略。離子載體包括拉薩羅、孟寧素和沙利黴素，而合成抗菌藥物包括硝基呋喃、奎諾酮和磺胺類藥物，突顯了它們在作用機制、監管考慮和治療定位方面的差異。離子載體通常用作特定生產系統中的連續飼料添加劑，而合成抗菌藥物則常用於標靶治療療程或輪換方案。市場細分考察了飼料添加劑、液體和預混合料三種劑型，每種劑型在劑量精度、農場實施便捷性和與現有飼料廠的整合性方面各有優劣。預混合料支持集約化飼料生產和穩定的劑量控制，飼料添加劑可實現大規模的連續預防，而液體劑型則允許在水性系統中靈活給藥，以進行靶向干預。

區域洞察聚焦在美洲、歐洲、中東和非洲以及亞太地區不同的促進因素及其對產品策略的影響。

區域性因素影響著監管重點、疾病壓力和採購行為。在美洲，生產規模、一體化供應鏈和加工商主導的品質管理系統正在催生對穩定、與飼料相容的球蟲的需求。在歐洲、中東和非洲，對某些合成化合物的監管審查以及對抗菌藥物管理的重視，正在推動兼顧療效和殘留風險的產品的普及。在許多歐洲市場，零售商的承諾和以動物福利主導的舉措也在影響人們轉向綜合管理方法，並減少對預防性藥物的依賴。

亞太地區生產體系和法規環境的複雜性，對需求和分銷模式均有影響。該地區部分地區家禽養殖密度高，對便捷、經濟的抗球蟲方案的需求強勁；同時，新的監管協調措施也提高了人們對殘留監測和品質保證的期望。此外，數位商務和不斷發展的獸醫服務正在加速亞太部分地區採用替代分銷管道。不同地區的抗藥性特徵、飼料廠密度以及合約養殖模式的普及程度，共同決定了哪些產品類型和形式更受青睞，凸顯了製定區域性監管策略和商業性模式的必要性。

對主要企業進行競爭考察，重點關注其策略行動、研發重點領域和合作模式，這些因素共同塑造了球蟲領域的競爭動態。

市場參與企業展現出多元化的策略姿態，這反映了他們的規模、產品組合廣度和垂直整合程度。大型跨國動物用藥品公司優先考慮配方穩定性、抗藥性緩解技術以及結合診斷和管理專案的綜合服務方面的創新。這些公司投資於全球監管能力建設，以應對不同的殘留和註冊要求，並通常採用多通路銷售模式，以涵蓋行業整合者和小型獨立生產商。中型和區域性製造商則利用接近性飼料廠網路和合約養殖叢集的優勢，專注於具有成本競爭力的配方、本地監管專業知識和供應鏈可靠性。

在整個價值鏈中，隨著企業尋求在不進行大量資本投資的情況下擴大產能，製造外包和聯合開發夥伴關係正變得越來越普遍。藥物研發商、學術機構和診斷服務提供者之間的合作研究協議旨在加速開發抗藥性監測工具和最佳化給藥方案。同時，飼料添加劑專家和預混合料供應商正透過產品客製化、技術服務和卓越的可追溯性來脫穎而出，以滿足一體化生產商的嚴苛需求。這些企業層面的舉措表明，市場競爭優勢正日益不再僅僅來自分子所有權，而是來自配方、監管關係、農場諮詢能力等方面的專業知識的整合。

為行業領導者提供切實可行的建議，以使其產品開發、商業策略和管理與不斷變化的市場現實保持一致。

行業領導者應優先考慮將產品功效與農場實踐和抗藥性管理相結合的綜合方法。投資診斷和監測夥伴關係將有助於提高治療性介入的針對性，並支持以數據主導的輪調和合併用藥策略，從而維持療效。同時，提高配方與常用飼料廠工作流程和灌服系統的兼容性，可以減少推廣應用的障礙，並提高給藥的準確性。這些技術投資應與獸醫和飼料管理人員的教育計劃相結合，以確保正確使用並強化管理原則。

在商業方面，企業應使其分銷策略多元化，包括加強直銷能力、與專業供應商合作以及調整數位化管道以擴大覆蓋範圍並保持品質保證。受貿易相關成本波動影響的企業應評估近岸外包方案、合約避險技巧以及供應商多元化，以維持業務連續性。最後，企業領導者必須積極與監管相關人員和加工商就殘留監測、標籤和可接受使用框架進行溝通。綜合運用這些措施，可以使商業性目標與維持長期療效這一必要條件保持一致。

調查方法：詳細說明資料收集、檢驗過程以及為確保研究結果的可靠性和適用性而採用的分析方法。

本研究採用混合方法，結合一手研究、二手文獻分析和供應鏈圖譜，建構了全面的依證。一級資訊來源包括對獸醫、飼料廠經營者、委託製造和分銷專業人員的結構化訪談，以了解實務情況和實施障礙。二級資訊來源包括關於球蟲生物學和治療效果的同行評審文獻、監管文件、產品標籤以及提供技術和政策背景的官方貿易文件。

數據採用三角驗證法，反覆最後覆核與文件層面的證據進行交叉核對，以檢驗趨勢並調和相互矛盾的解釋。在適用情況下，我們查閱了區域監管資料庫和海關文件，以了解關稅和登記限制的影響。我們的分析方法著重於定性主題綜合和區域比較分析，而非定量市場規模評估，從而確保方法論的透明度，同時提供可操作的策略資訊。本研究的局限性包括各國和各地區報告標準的差異以及抗藥性監測數據的不斷變化，這些局限性在本研究中透過保守的解釋和對證據強度的清晰呈現來解決。

結論：概述了從事球蟲領域工作的相關人員的戰略要務以及實現永續治療效果的途徑。

球蟲市場格局正受到科學進步、監管環境、分銷模式轉變和貿易動態的影響而重塑。維持治療效果需要整合策略，將產品創新與管理、穩健的供應鏈設計以及有針對性的商業性合作相結合。成功的公司將是那些能夠將製劑研發與農場實踐相結合、投資於抗藥性監測夥伴關係並採用既能保證品質又能擴大可及性的分銷模式的公司。

展望未來，相關人員應將抗藥性管理和監管一致性視為核心策略重點，而非將合規視為事後考慮。這樣做將保障療效，支持動物福利和食品安全目標，並為加工商和生產商提供差異化的提案主張。未來幾年，對診斷、配方相容性和適應性採購的關注將決定市場競爭格局，並促進球蟲在不同生產系統中的永續利用。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 艾美球蟲對傳統離子載體藥物抗藥性的增強促進了新型合成球蟲藥物的研發。
  • 利用精密農業監測工具最佳化家禽養殖場球蟲藥物給藥方案
  • 擴大針對有機和自由放養養雞生產商的草藥和植物性球蟲產品範圍
  • 生物技術新興企業公司與動物保健公司建立策略夥伴關係，以加速開發基於疫苗的抗球蟲解決方案
  • 整合腸道微生物組分析以客製化球蟲方案並改善畜群健康狀況
  • 對抗生素生長促進劑的更嚴格監管正在加速向疫苗接種和替代性球蟲控制方法的轉變。
  • 結合離子載體和化學活性劑開發抗多重抗藥性球蟲藥物
  • 利用機器學習預測模型對肉雞養殖場球蟲疫情進行早期檢測與標靶治療

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依最終用途球蟲藥物市場

  • 牛
  • 家禽
    • 肉雞
    • 下層雞
  • 豬

9. 按分銷管道分類的球蟲藥市場

  • 直銷
  • 網路藥房
  • 專賣店

第10章 依產品類型分類的球蟲藥市場

  • 離子載體
    • 拉薩羅
    • 孟寧素
    • 沙利黴素
  • 合成藥物
    • 硝基呋喃
    • 奎諾酮
    • 磺胺類藥物

11. 按劑型分類的球蟲藥市場

  • 飼料添加劑
  • 液體
  • 預混合料

12. 各地區球蟲藥市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章球蟲藥市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國球蟲藥市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Zoetis Inc.
    • Merck & Co., Inc.
    • Elanco Animal Health Incorporated
    • Boehringer Ingelheim International GmbH
    • Bayer Aktiengesellschaft
    • Ceva Sante Animale
    • Kemin Industries, Inc.
    • Huvepharma AD
    • Novus International, Inc.
    • DCBL Pharmaceuticals Ltd.
Product Code: MRR-456C7E8666FE

The Anticoccidial Drugs Market is projected to grow by USD 3.71 billion at a CAGR of 9.71% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.76 billion
Estimated Year [2025] USD 1.93 billion
Forecast Year [2032] USD 3.71 billion
CAGR (%) 9.71%

A concise introduction framing the strategic importance of anticoccidial therapies in modern livestock health management

Anticoccidial drugs remain central to maintaining gastrointestinal health and production efficiency across intensively managed livestock systems. As the industry has intensified, the role of targeted chemoprophylaxis and therapeutic interventions has expanded to address disease pressure that would otherwise undermine productivity, animal welfare, and feed conversion outcomes. In this context, understanding the evolving landscape of anticoccidial approaches is essential for veterinary teams, feed manufacturers, regulatory bodies, and commercial stakeholders seeking to balance efficacy, safety, and sustainability.

This report synthesizes recent scientific advances, regulatory movements, distribution channel evolution, and end-use dynamics to provide an integrated view of contemporary anticoccidial practice. It examines how product formulation choices, shifts in species-specific husbandry, and emerging resistance patterns are influencing treatment selection and supply chain decisions. By establishing a clear baseline of current practice and emerging pressures, the analysis supports evidence-based planning for research investment, market entry, and policy engagement.

Throughout the analysis, emphasis is placed on pragmatic implications for decision-makers: how formulation and delivery choices intersect with on-farm workflows, how distribution models affect accessibility and stewardship, and how regulatory and trade developments influence sourcing and manufacturing strategies. The introduction thus frames the subsequent sections that explore transformative shifts, tariff impacts, segmentation insights, regional nuances, competitor behavior, actionable recommendations, methodology, and the overarching conclusions that guide operational and strategic responses.

Transformative shifts reshaping anticoccidial drug development, use patterns, and stewardship across animal agriculture

Recent years have seen a convergence of scientific, regulatory, and market drivers that are transforming how anticoccidial therapies are developed, distributed, and deployed. Advances in pathogen genomics and in vitro susceptibility testing have improved the capacity to detect and monitor resistance, enabling more targeted product development and localized treatment strategies. At the same time, animal welfare imperatives and retailer-driven quality standards are pushing producers to reassess prophylactic approaches and favor integrated disease management practices that reduce blanket medicated feed usage.

Concurrently, the product landscape is evolving. Ionophores continue to be valued for their efficacy and feed-additive compatibility, while synthetic compounds remain critical in therapeutic contexts where resistance or specific lifecycle stages necessitate their use. Formulation innovation-such as improved premixes and stabilized liquids-has increased dosing precision and ease of integration into feed and water systems. Distribution channels are also shifting; direct sales relationships and specialty veterinary channels are strengthening, while digital platforms and online pharmacies expand accessibility and alter purchasing behavior.

Moreover, sustainability and regulatory compliance considerations are driving supply chain reconfiguration. Manufacturers and feed integrators are investing in upstream quality control, traceability, and alternative sourcing to mitigate exposure to trade disruptions and regulatory changes. Taken together, these shifts are recalibrating competitive dynamics, research priorities, and operational practices across the anticoccidial ecosystem, demanding adaptive strategies from pharmaceutical developers, contract manufacturers, feed companies, and veterinary service providers.

Analyzing the cumulative operational and strategic consequences of United States tariffs announced in 2025 on anticoccidial supply chains and procurement

The tariff measures introduced in 2025 have had ripple effects across the supply chains that support anticoccidial drug availability, manufacturing inputs, and distribution economics. Import duties on certain active pharmaceutical ingredients and intermediary feed materials have increased landed costs for manufacturers and feed mills that rely on international sourcing. In response, procurement teams have re-evaluated supplier portfolios, prioritized alternative origins, and escalated conversations with contract manufacturers to identify cost-saving production windows and mitigate margin erosion.

These tariff-driven adjustments have also accelerated nearshoring conversations and investments. Companies with flexible manufacturing footprints have reallocated production or increased inventory buffers to preserve supply continuity. Simultaneously, smaller producers and regional feed integrators have faced more pronounced cost pressures due to limited hedging capabilities, prompting consolidation and strategic partnerships to share scale advantages. Regulatory compliance and customs complexity introduced by tariffs have added administrative overhead, increasing time-to-delivery and influencing ordering cadence.

Importantly, distribution channels have adapted to tariff-induced cost volatility. Direct-sales teams and specialty distributors have intensified value-based conversations with customers, emphasizing formulation benefits and stewardship programs that justify premium pricing. Online pharmacies and digital procurement platforms have helped some buyers source alternative formulations or generics from non-impacted jurisdictions, though quality assurance and regulatory conformity remain primary considerations. Overall, the cumulative impact of tariffs has reshaped sourcing strategies, compelled operational resilience investments, and influenced commercial positioning across the anticoccidial value chain.

Key segmentation insights synthesizing end use, distribution channels, product types, and formulation choices to inform targeted strategic initiatives

Segmenting the market clarifies where therapeutic demand and adoption barriers intersect. Based on end use, the market is studied across cattle, poultry, and swine, with poultry further examined through the distinct production systems of broiler chicken and layer chicken; these species- and system-level differences drive divergent treatment timing, dosing strategies, and integration with feed management practices. Feed additive formulations and in-water therapeutics align differently with broiler cycles versus layer management, creating separate product development and marketing imperatives. Transitioning between therapeutic classes within a species depends on production scale, biosecurity protocols, and retailer or processor specifications.

Considering distribution channel segmentation, the market is studied across direct sales, online pharmacies, and specialty stores, each offering distinct pathways to end users and varying degrees of technical support. Direct sales relationships often support integrated stewardship programs and formalized dosing guidance, while online pharmacies expand access but require robust digital information to preserve correct usage. Specialty stores play a key role in regions with dense independent veterinary practices and feed cooperatives, providing localized advisory services that influence product choice and adherence to recommended protocols.

Product type segmentation clarifies clinical application and resistance management strategies. The market is studied across ionophores and synthetic drugs, with ionophores further studied across lasalocid, monensin, and salinomycin, while synthetic drugs are further studied across nitrofurans, quinolones, and sulfonamides; this taxonomy highlights differing mechanisms of action, regulatory considerations, and therapeutic niches. Ionophores are commonly employed as continuous feed additives in certain production systems, whereas synthetics are more often used for targeted therapeutic courses or in rotation programs. Form-based segmentation reveals how delivery impacts adoption: the market is studied across feed additive, liquid, and premix forms, each providing trade-offs in dosing accuracy, ease of on-farm implementation, and integration with existing feed mill operations. Premix formats support centralized feed production and consistent dosing, feed additives enable continuous prophylaxis at scale, and liquids offer flexible administration in water systems for targeted interventions.

Regional insights highlighting heterogenous drivers across the Americas, Europe, Middle East & Africa, and Asia-Pacific and their implications for product strategy

Regional dynamics shape regulatory priorities, disease pressures, and procurement behavior. In the Americas, production scale, integrated supply chains, and processor-led quality programs create demand for consistent, feed-compatible anticoccidial solutions; producers often favor products that align with high-throughput systems and stringent food-safety requirements. Across Europe, Middle East & Africa, regulatory scrutiny on certain synthetic compounds and strong emphasis on antimicrobial stewardship steer product adoption toward options that balance efficacy and residue risk. Retailer commitments and welfare-driven initiatives in many European markets also influence the transition toward integrated management approaches and reduced prophylactic reliance.

Asia-Pacific presents a mosaic of production systems and regulatory environments that influence both demand and distribution models. High-density poultry production in parts of the region sustains robust demand for accessible, cost-effective anticoccidial programs, while emerging regulatory harmonization efforts are increasing expectations around residue monitoring and quality assurance. Concurrently, digital commerce and evolving veterinary services in parts of Asia-Pacific accelerate adoption of alternative distribution channels. Across regions, localized resistance profiles, feed mill density, and the prevalence of contract farming models combine to determine which product types and forms gain traction, underscoring the need for regionally adapted regulatory strategies and commercial playbooks.

Key company insights emphasizing strategic behaviors, R&D focus areas, and collaborative models shaping competitive dynamics in the anticoccidial space

Market participants exhibit diverse strategic postures that reflect their scale, portfolio breadth, and vertical integration. Large multinational animal health firms prioritize innovation in formulation stability, resistance mitigation technologies, and integrated service offerings that bundle diagnostics and stewardship programs. These organizations invest in global regulatory affairs capabilities to navigate differing residue and registration requirements and often deploy multi-channel distribution models to reach both industrial integrators and smaller independent producers. Mid-sized and regional manufacturers focus on cost-competitive formulations, local regulatory expertise, and supply chain reliability, leveraging proximity to feed mill networks and contract farming clusters.

Across the value chain, contract manufacturing and co-development partnerships have become more common as companies seek to expand capacity without incurring full-scale capital commitments. Collaborative research arrangements between pharmaceutical developers, academic institutions, and diagnostic providers aim to accelerate resistance monitoring tools and refined dosing regimens. Meanwhile, specialized feed additive firms and premix suppliers are differentiating through product customization, technical services, and superior traceability to meet the exacting needs of integrated producers. These company-level behaviors indicate a market where competitive advantage increasingly derives from combined expertise in formulation, regulatory navigation, and on-farm advisory capability rather than solely from molecule ownership.

Actionable recommendations for industry leaders to align product development, commercial strategy, and stewardship with evolving market realities

Industry leaders should prioritize integrated approaches that link product efficacy with on-farm implementation and resistance management. Investing in diagnostics and surveillance partnerships will improve the targeting of therapeutic interventions and support data-driven rotation or combination strategies that preserve efficacy. In parallel, enhancing formulation compatibility with common feed mill workflows and water medication systems will reduce barriers to adoption and improve dosing accuracy. These technical investments should be coupled with educational programs for veterinarians and feed managers to ensure correct use and to reinforce stewardship principles.

On the commercial front, firms should diversify distribution strategies to include strengthened direct-sales capabilities, partnerships with specialty providers, and compliant digital channels that expand reach while maintaining quality assurance. Companies exposed to trade-related cost volatility should evaluate nearshoring options, contractual hedging practices, and supplier diversification to preserve continuity. Finally, leaders must proactively engage regulatory stakeholders and processors on residue monitoring, labeling, and acceptable usage frameworks, because early alignment can de-risk launches and facilitate smoother market access across jurisdictions. Taken together, these measures will help reconcile commercial objectives with the imperative to maintain long-term therapeutic effectiveness.

Research methodology detailing data collection, validation processes, and analytical techniques used to ensure reliability and applicability of findings

The research draws upon a mixed-methods approach combining primary interviews, secondary literature analysis, and supply chain mapping to build a comprehensive evidence base. Primary inputs included structured interviews with veterinarians, feed mill managers, contract manufacturers, and distribution specialists to capture operational realities and adoption barriers. Secondary sources included peer-reviewed literature on coccidiosis biology and treatment efficacy, regulatory filings, product labels, and public trade documentation to corroborate technical and policy contexts.

Data were triangulated to validate trends and reconcile conflicting accounts, with iterative cross-checking between field insights and document-level evidence. Where applicable, regional regulatory databases and customs documentation were consulted to understand tariff impacts and registration constraints. Analytical techniques emphasized qualitative thematic synthesis and comparative regional analysis rather than numerical market sizing, ensuring the report provides actionable strategic intelligence while maintaining methodological transparency. Limitations include variability in reporting standards across jurisdictions and the evolving nature of resistance surveillance data, which the research addresses through conservative interpretation and clear signaling of evidence strength.

Conclusion summarizing the strategic imperatives for stakeholders operating in the anticoccidial domain and the pathways to sustainable therapeutic effectiveness

The anticoccidial landscape is being reshaped by scientific advances, regulatory pressures, shifting distribution models, and trade dynamics. Maintaining therapeutic effectiveness will require integrated strategies that link product innovation with stewardship, robust supply chain design, and targeted commercial engagement. Companies that succeed will be those that align formulation development with on-farm practices, invest in resistance monitoring partnerships, and adopt distribution models that preserve quality while expanding access.

Moving forward, stakeholders should treat resistance management and regulatory alignment as central strategic priorities rather than compliance afterthoughts. By doing so, they will protect efficacy, support animal welfare and food-safety objectives, and create differentiable value propositions for processors and producers. The combined emphasis on diagnostics, formulation compatibility, and adaptive sourcing will define competitiveness in the coming years, enabling sustainable use of anticoccidial interventions across diverse production systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising Eimeria species resistance to traditional ionophore drugs driving development of novel synthetic anticoccidials
  • 5.2. Adoption of precision agriculture monitoring tools to optimize anticoccidial dosing schedules in poultry operations
  • 5.3. Expansion of herbal and phytogenic anticoccidial formulations targeting organic and free range poultry producers
  • 5.4. Strategic partnerships between biotech startups and animal health firms accelerating vaccine based anticoccidial solutions
  • 5.5. Integration of gut microbiome analysis to customize anticoccidial protocols and improve flock health outcomes
  • 5.6. Increased regulatory restrictions on antibiotic growth promoters accelerating shift to vaccination and alternative coccidiosis control
  • 5.7. Development of combination chemistries pairing ionophore and chemical actives to combat multidrug resistant coccidia strains
  • 5.8. Use of machine learning predictive models for early detection and targeted treatment of coccidiosis outbreaks in broiler farms

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Anticoccidial Drugs Market, by End Use

  • 8.1. Cattle
  • 8.2. Poultry
    • 8.2.1. Broiler Chicken
    • 8.2.2. Layer Chicken
  • 8.3. Swine

9. Anticoccidial Drugs Market, by Distribution Channel

  • 9.1. Direct Sales
  • 9.2. Online Pharmacies
  • 9.3. Specialty Stores

10. Anticoccidial Drugs Market, by Product Type

  • 10.1. Ionophores
    • 10.1.1. Lasalocid
    • 10.1.2. Monensin
    • 10.1.3. Salinomycin
  • 10.2. Synthetic Drugs
    • 10.2.1. Nitrofurans
    • 10.2.2. Quinolones
    • 10.2.3. Sulfonamides

11. Anticoccidial Drugs Market, by Form

  • 11.1. Feed Additive
  • 11.2. Liquid
  • 11.3. Premix

12. Anticoccidial Drugs Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Anticoccidial Drugs Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Anticoccidial Drugs Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Zoetis Inc.
    • 15.3.2. Merck & Co., Inc.
    • 15.3.3. Elanco Animal Health Incorporated
    • 15.3.4. Boehringer Ingelheim International GmbH
    • 15.3.5. Bayer Aktiengesellschaft
    • 15.3.6. Ceva Sante Animale
    • 15.3.7. Kemin Industries, Inc.
    • 15.3.8. Huvepharma AD
    • 15.3.9. Novus International, Inc.
    • 15.3.10. DCBL Pharmaceuticals Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. ANTICOCCIDIAL DRUGS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. ANTICOCCIDIAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANTICOCCIDIAL DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY BROILER CHICKEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY BROILER CHICKEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY BROILER CHICKEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY BROILER CHICKEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY BROILER CHICKEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY BROILER CHICKEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LAYER CHICKEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LAYER CHICKEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LAYER CHICKEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LAYER CHICKEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LAYER CHICKEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LAYER CHICKEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LASALOCID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LASALOCID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LASALOCID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LASALOCID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LASALOCID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LASALOCID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY MONENSIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY MONENSIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY MONENSIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY MONENSIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY MONENSIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY MONENSIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SALINOMYCIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SALINOMYCIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SALINOMYCIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SALINOMYCIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SALINOMYCIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SALINOMYCIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY NITROFURANS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY NITROFURANS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY NITROFURANS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY NITROFURANS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY NITROFURANS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY NITROFURANS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY QUINOLONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY QUINOLONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY QUINOLONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY QUINOLONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY QUINOLONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY QUINOLONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SULFONAMIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SULFONAMIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SULFONAMIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SULFONAMIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FEED ADDITIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FEED ADDITIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FEED ADDITIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FEED ADDITIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PREMIX, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PREMIX, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PREMIX, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PREMIX, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PREMIX, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PREMIX, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 220. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 222. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 226. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 235. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 236. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 237. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 238. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 239. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 242. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 243. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 244. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 268. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 269. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 270. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 271. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 272. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 273. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 276. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 279. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 280. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 281. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 284. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 285. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 288. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 289. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 292. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 293. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 294. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 295. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 296. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 313. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 316. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 317. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 318. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 319. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 320. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 321. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 324. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 325. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 326. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 327. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 328. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 329. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 330. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 331. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 332. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 333. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 334. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 335. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 336. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 337. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 338. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 339. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 340. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 341. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 342. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 343. G7 ANTI